AghaAmiri earns 2022 NANETS Grant

The North American Neuroendocrine Tumor Society (NANETS) has awarded Solmaz AghaAmiri, PhD, post-doctoral researcher in the Center for Translational Cancer Research at the Brown Foundation Institute of Molecular Medicine, as the 2022 recipient of NANETS Theranostics Investigator Grant (NTIG). AghaAmiri…


Tsuchikama lab develops promising treatment for brain tumors

Recent research from the lab of Kyoji Tsuchikama, PhD, associate professor in the Texas Therapeutics Institute at the Brown Foundation Institute for Molecular Medicine, showing the ability of their antibody-drug conjugate (ADC) to deliver anti-tumor payloads to brain tumors has…


Kolonin research on diabetes associated with obesity published

Recent research from the lab of Mikhail Kolonin, PhD, professor in the Brown Foundation Institute of Molecular Medicine, makes an important step toward understanding and confronting diabetes associated with obesity. In previous studies, Kolonin and colleagues have developed an experimental…


NIH grant funds novel hydrocephalus research

A five-year, $2.85 million grant to use novel technology to study babies with hydrocephalus has been awarded to a team of McGovern Medical School researchers by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of…


An earns National Academy of Inventors fellowship

Zhiqiang An, PhD, professor and director of the Texas Therapeutics Institute of the Brown Foundation Institute of Molecular Medicine, has been named a fellow of the National Academy of Inventors (NAI), the organization announced Dec. 7. “I am honored that…


Nature Communications features Tong’s research on reducing diabetic hyperglycemia

Recent research from the lab of Qingchun Tong, PhD, professor and Cullen Chair in Molecular Medicine at The Brown Foundation Institute of Molecular Medicine, has been published in Nature Communications. The paper titled “A neural basis for brain leptin action…


Research on antibody-drug conjugates shows promise in fighting breast cancer

Research from the lab of Kyoji Tsuchikama, PhD, assistant professor in the Texas Therapeutics Institute at The Brown Foundation Institute of Molecular Medicine, on a new potential treatment for combating breast cancer has been published in the June edition of…


New antibody therapies found to potentially fight COVID-19

Researchers at McGovern Medical School and The University of Texas Medical Branch at Galveston (UTMB Health) have discovered a potential new antibody therapy for COVID-19. The study was published in Nature Communications. Antibodies are proteins that allow the body to fight viruses such as…


Harry E. Bovay, Jr. Lecture Set for Jan. 24

David Sabatini, MD, PhD, professor of biology at the Massachusetts Institute of Technology, will present the 2020 Harry E. Bovay, Jr. Annual Lecture on “mTOR and the Regulation of Metabolism.” The lecture will be held at 11 a.m. on Jan….


Scientists generate functional, transplantable B cells

Functional B-1 cells derived from mouse embryonic stem cells secrete natural antibodies and are capable of long-term engraftment after transplantation in mice, according to a study published by Cell Press on Feb. 7 in Stem Cell Reports. If translated to…


Pages